Post-COVID-19 epidemiology of pneumococcal disease in Taiwan: escalating serotype replacement and antimicrobial resistance in all ages
Highlights • Incidence of CCPD rose to 9.04 per 100,000 population in the post-pandemic 2024. • Lower β-lactam susceptibility of the pneumococcal isolates is due to serotype shift. • Resistant non-PCV13 clones are emerging from clonal expansion and capsular switch.